Abstract P248 – Table 1. Demographic and clinical characteristics of the study population.
	LP‐PLWH (n = 20)	HCWs (n = 20)	p‐value LP‐PLWH vs HCWsa
Age, years, median (IQR)	57 (47 to 62)	55 (45 to 61)	0.3500
Sex, n (%)			0.1908
Male	15 (75)	10 (50)
Female	5 (25)	10 (50)
Ethnicity, n (%)			0.1264
Caucasian	15 (75)	20 (100)
Latin‐American	3 (15)	0 (0)
Afro‐American	1 (5)	0 (0)
African	1 (5)	0 (0)
Comorbidities, n (%)
Hypertension	5 (25)	2 (10)	0.4075
Chronic heart disease	2 (10)	0 (0)	0.4872
Myocardial infarction	1 (5)	0 (0)	>0.9999
Peripheral vascular disease	1 (5)	0 (0)	>0.9999
Chronic pulmonary disease	2 (10)	2 (10)	>0.9999
Chronic kidney disease	2 (10)	1 (5)	>0.9999
Liver disease	3 (15)	0 (0)	0.2308
Diabetes	3 (15)	0 (0)	0.2308
Charlson comorbidity index,b median (IQR)	2 (0 to 4)	1 (0 to 2)	0.1153
Epidemiology, n (%)
MSM	8 (40)
IDU	2 (10)
Other	10 (50)
Viro‐immunological parameters, median (IQR)
CD4 nadir, cells/μL	67 (32 to 215)
HIV‐RNA zenith, copies/mL	60 816 (22 402 to 242 511)
Current % CD4	25 (12 to 30)
Current CD4, cells/μL	404 (192 to 615)
Current % CD8	46 (35 to 60)
Current CD8, cells/μL	809 (590 to 1008)
Current CD4/CD8 ratio	0.57 (0.20 to 0.87)
Current HIV‐RNA, copies/mL	<20
Previous AIDS diagnosis, n (%)	8 (40)
Current cART regimen, n (%)
INSTI‐based triple	11 (55)
INSTI‐based dual	6 (30)
NNRTI‐based triple	3 (15)
Duration of cART, years, median (IQR)	12 (6 to 17)

cART, combination antiretroviral therapy; HCWs, healthcare workers; IDU, injective drugs use; INSTI, integrase strand transfer inhibitor; IQR, interquartile range; LP‐PLWH, late presenter people living with HIV.

^aStatistical analyses: Mann‐Whitney U test, Fisher exact test, Chi‐square test, as appropriate;

^bage‐adjusted.